Home LiteratureArticle Details
PMID: 2488098 Published · ppublish English Journal Article Review

Nitrate tolerance in angina pectoris.

Cardiovascular drugs and therapy ·Vol. 2 ·No. 6 ·1989-01-00 ·Pages 823-9

Parker JO

Abstract

Tolerance to the hemodynamic and antianginal effects of the organic nitrates develops rapidly during therapy. This has been documented with a variety of nitrate preparations and with different routes of administration. Dosing strategies designed to provide therapeutic plasma nitrate concentrations throughout the 24 hours of the day are regularly associated with the development of tolerance. Recent information indicates that dosing schedules providing a nitrate-free period will permit continued efficacy of the organic nitrates without tolerance development. This can be accomplished in several ways. With oral preparations of isosorbide dinitrate, medication can be given 3 times daily, omitting the evening dose. Buccal nitroglycerin is usually given 3 times daily after meals, and this has been shown not to be associated with tolerance. Likewise, preliminary studies suggest that removal of the nitroglycerin patches for a period of several hours each day will prevent the development of tolerance. Much needs to be learned about the nitrate-free period. With oral isosorbide dinitrate, it appears that 12 hours is required, but this could be substantially less with nitroglycerin preparations. It is also possible that several short periods with low nitrate levels each day would suffice. Thus, simply increasing the interval between dosing of oral preparations may provide an adequate, low, nitrate-free period.

MeSH Terms
Angina Pectoris/drug therapy,physiopathology Animals Drug Tolerance Female Humans Male Nitrates/therapeutic use
Chemicals
Nitrates
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Parker J O
Department of Medicine, Queen's University, Kingston, Ontario, Canada.
References (31)
31 references, click to expand
  1. A preliminary double-blind study of intravenous nitroglycerin in acute myocardial infarction.
    Intensive Care Med. 1984;10(4):179-84 PMID: 6432869
  2. Nitroglycerin ointment effective for seven hours in severe angina pectoris.
    Acta Med Scand. 1983;213(3):165-70 PMID: 6405584
  3. Potentiation of nitroglycerin-induced coronary dilatation by N-acetylcysteine.
    Circulation. 1986 Jan;73(1):138-42 PMID: 3079676
  4. Hemodynamics and antianginal effects of high dose oral isosorbide dinitrate after chronic use.
    Circulation. 1977 Aug;56(2):205-12 PMID: 406098
  5. Transdermal isosorbide dinitrate in angina pectoris: effect of acute and sustained therapy.
    Am J Cardiol. 1984 Jul 1;54(1):8-13 PMID: 6430057
  6. Nitrate tolerance: influence of isosorbide dinitrate on the hemodynamic and antianginal effects of nitroglycerin.
    J Am Coll Cardiol. 1983 Jul;2(1):115-20 PMID: 6406586
  7. Pharmacokinetics of nitroglycerin and long-acting nitrate esters.
    Am J Med. 1983 Jun 27;74(6B):13-20 PMID: 6407312
  8. Nitrate tolerance: the lack of effect of N-acetylcysteine.
    Circulation. 1987 Sep;76(3):572-6 PMID: 3304705
  9. Mechanism of tolerance development to organic nitrates.
    J Pharmacol Exp Ther. 1973 Mar;184(3):709-15 PMID: 4631470
  10. Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance.
    Ann Intern Med. 1986 Oct;105(4):485-92 PMID: 3092711
  11. Prevention of tolerance to nitroglycerin patches by overnight removal.
    Am J Cardiol. 1987 Aug 1;60(4):271-5 PMID: 3113223
  12. Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy.
    Am J Cardiol. 1982 Feb 1;49(2):411-9 PMID: 7058754
  13. The clinical use of transdermal delivery devices with nitroglycerin.
    Angiology. 1983 Jan;34(1):23-31 PMID: 6401952
  14. Comparison of buccal nitroglycerin and oral isosorbide dinitrate for nitrate tolerance in stable angina pectoris.
    Am J Cardiol. 1985 Nov 1;56(12):724-8 PMID: 3933317
  15. Organic nitrates: relationship between biotransformation and rational angina pectoris therapy.
    J Pharmacol Exp Ther. 1972 Jun;181(3):489-97 PMID: 4624401
  16. Nitrate tolerance and dependence.
    Am Heart J. 1980 Jan;99(1):113-23 PMID: 6766045
  17. Effects of long-term oral administration of isosorbide dinitrate on the antianginal response to nitroglycerin. Absence of nitrate cross-tolerance and self-tolerance shown by exercise testing.
    Am J Cardiol. 1978 Jan;41(1):82-7 PMID: 414612
  18. Nonatheromatous ischemic heart disease following withdrawal from chronic industrial nitroglycerin exposure.
    Circulation. 1972 Oct;46(4):666-78 PMID: 4627365
  19. Antianginal effects of nitroglycerin patches.
    Am J Cardiol. 1984 Jul 1;54(1):1-7 PMID: 6430053
  20. Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrate.
    Circulation. 1980 Mar;61(3):526-35 PMID: 6766360
  21. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates.
    J Pharmacol Exp Ther. 1981 Sep;218(3):739-49 PMID: 6115052
  22. Clearance and metabolism of organic nitrates.
    J Pharmacol Exp Ther. 1972 Jul;182(1):56-62 PMID: 4625289
  23. Transdermal nitroglycerin in angina pectoris.
    Am J Cardiol. 1984 Sep 1;54(6):471-6 PMID: 6433687
  24. Tolerance to isosorbide dinitrate: rate of development and reversal.
    Circulation. 1983 Nov;68(5):1074-80 PMID: 6616789
  25. Tolerance development during isosorbide dinitrate treatment: can it be circumvented?
    Z Kardiol. 1983;72 Suppl 3:195-8 PMID: 6421009
  26. Antianginal effects of intravenous nitroglycerin over 24 hours.
    Circulation. 1988 Jun;77(6):1376-84 PMID: 3131041
  27. Sustained effects of nitroglycerin ointment in patients with angina pectoris.
    Circulation. 1974 Aug;50(2):348-52 PMID: 4211087
  28. Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine.
    Circulation. 1983 Dec;68(6):1247-53 PMID: 6139183
  29. Oral isosorbide dinitrate in the treatment of angina pectoris. Dose-response relationship and duration of action during acute therapy.
    Circulation. 1980 Sep;62(3):491-502 PMID: 7398008
  30. Impact of captopril on hemodynamic and hormonal effects of nitroprusside.
    J Cardiovasc Pharmacol. 1985 Sep-Oct;7(5):869-74 PMID: 2413294
  31. Effect of intervals between doses on the development of tolerance to isosorbide dinitrate.
    N Engl J Med. 1987 Jun 4;316(23):1440-4 PMID: 3574424
Article Info
Journal
Cardiovascular drugs and therapy
Abbr.
Cardiovasc Drugs Ther
ISSN
0920-3206
Published
1989-01-00
Pages
823-9
Language
English
Region
United States
NLM ID
8712220
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]